In this study, Jones et al. reported a marked difference in survival between patients with V600E BRAF-mutant metastatic CRC and those with non-V600E BRAF-mutant CRC (median OS 11.4 vs. 60.7 months, respectively) [60]. Here, BRAF is linked to colorectal carcinoma.